Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.

Por Borg, A., Lennerstrand, J., Stenmark-Askmalm, M., Fernö, M., Brisfors, A., Ohrvik, A., Stål, O., Killander, D., Lane, D., Brundell, J.
Publicado em 1995